Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mojirade Taibat Bakare-Odunola"'
Autor:
Bulus Adzu, Sambo Godwin Ishaku, Magaji Garba, Ibrahim Adamu Yakasai, A Musa, Mojirade Taibat Bakare-Odunola
Publikováno v:
International Journal of Biological and Chemical Sciences. 14:2267-2276
Diabetic patients do have co-occurring diseases like malaria, especially in tropical regions. Hence, polypharmacy is sometimes unavoidable. Gliclazide is widely used in the treatment of non-insulin-dependent type 2 diabetes mellitus, while dihydro-ar
Autor:
Magaji Garba, A Musa, Sambo Godwin Ishaku, Mojirade Taibat Bakare-Odunola, Ibrahim Adamu Yakasai, Bulus Adzu
Publikováno v:
African Journal of Pharmacy and Pharmacology. 13:139-145
The study aims at investigating the effect of amodiaquine on the pharmacokinetic profile of gliclazide. It is a one-way single dose cross-over study in two phases. Six freshly diagnosed diabetic volunteers were used. The subjects acted as their own c
Autor:
Sambo Godwin Ishaku, A Musa, Ibrahim Adamu Yakasai, Bulus Adzu, Magaji Garba, Mojirade Taibat Bakare-Odunola
Publikováno v:
International Journal of Biological and Chemical Sciences; Vol 13, No 4 (2019); 2104-2111
Therapeutic management of diabetic patients frequently involves polypharmacy which is likely to provoke drug-drug interactions (DDIs). This may require appropriate monitoring and most common clinically relevant DDIs that occur with antidiabetic medic